Does acute stress play a role in the lasting therapeutic effects of psychedelic drugs?

© 2023. The Author(s), under exclusive licence to American College of Neuropsychopharmacology..

Psychedelic drugs, when used in the context of psychotherapy, can produce significant and long-lasting memories with enduring beneficial effects. Yet, the behavioral and neurobiological mechanisms that underlie these beneficial effects remain a mystery. Here, we suggest that both the quality and durability of memories of the drug-facilitated therapeutic experience may be mediated, in part, by the acute stress responses induced by the drugs. It is known that high doses of psychedelic drugs activate autonomic and hormonal stress responses. For evolutionarily adaptive reasons, acute stress is known to i) instill meaning to the immediate context in which it is experienced, and ii) lead to the formation of salient and lasting memories of the events surrounding the stress. Thus, the stress-inducing effect of psychedelic drugs may contribute to the reported sense of meaning, as well as the durability of the memory of the drug experience. When used in a therapeutic context these actions may i) enhance the salience of insights gained during the experience and ii) strengthen the memories formed by these experiences. Future empirical studies will help to determine whether acute stress contributes to the emotional significance and lasting effects of psychedelic-assisted psychotherapy.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:48

Enthalten in:

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology - 48(2023), 10 vom: 30. Sept., Seite 1422-1424

Sprache:

Englisch

Beteiligte Personen:

de Wit, H [VerfasserIn]
Heilig, M [VerfasserIn]
Bershad, A K [VerfasserIn]

Links:

Volltext

Themen:

Hallucinogens
Journal Article
Review

Anmerkungen:

Date Completed 17.08.2023

Date Revised 03.10.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1038/s41386-023-01642-z

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM358928389